EUR 2m contract with leading European biotech

RNS Number : 8174P

Venn Life Sciences Holdings PLC

10 June 2015

 

10 June 2015

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

Venn Signs €2m Contract with Leading European Biotech

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology, academic and medical device clients, announces today the signing of a €2m contract with a leading European Biotechnology company.

The Phase III study, in the area of Rheumatology, will cover multiple European countries, commences immediately and will run over 4 years with a high concentration of activity in year one. Venn has extensive experience in the management of Phase III trials with an excellent track record of multi-site and multi-cultural clinical trials. The contract win comes on the back of Venn reporting a 140% revenue increase in 2014 and €4.1m of new contracts in March of this year with a US based Biotechnology company.

Speaking about the agreement, Venn CEO, Tony Richardson stated: "The signing of this contract reinforces the continued success of our clinical and business development teams to win projects with leading international organisations. Venn has been steadily and continuously delivering on its strategy to win larger multi country scale contracts and to increase its footprint across Europe."

Enquiries:

Venn Life Sciences Holdings Plc	www.vennlifesciences.com
Tony Richardson, Chief Executive Officer	Tel: [phone]
Orla Mc Guinness, Marketing Manager	Tel: [phone]
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones	Tel: [phone]
Alex Davies	Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

 

END

 

 

MSCSFIFLSFISELM